Terms: = Breast cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310
42 results:
1. SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1.
Deng L; Liao L; Zhang YL; Yang SY; Hu SY; Andriani L; Ling YX; Ma XY; Zhang FL; Shao ZM; Li DQ
Sci Adv; 2024 Apr; 10(14):eadj4009. PubMed ID: 38569025
[TBL] [Abstract] [Full Text] [Related]
2. Spermatid perinuclear RNA-binding protein promotes ubr5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.
Chen SY; Zhang FL; Zhang YL; Liao L; Deng L; Shao ZM; Liu GY; Li DQ
Cancer Lett; 2024 Apr; 586():216672. PubMed ID: 38280476
[TBL] [Abstract] [Full Text] [Related]
3. Targeting ubr5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal cancer.
Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
[TBL] [Abstract] [Full Text] [Related]
5. ubr5 promotes tumor immune evasion through enhancing IFN-γ-induced
Wu B; Song M; Dong Q; Xiang G; Li J; Ma X; Wei F
Theranostics; 2022; 12(11):5086-5102. PubMed ID: 35836797
[No Abstract] [Full Text] [Related]
6. Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.
Zhao Y; Huang X; Zhu D; Wei M; Luo J; Yu S; Tian Y; Zheng X
Cell Death Differ; 2022 Dec; 29(12):2531-2544. PubMed ID: 35768646
[TBL] [Abstract] [Full Text] [Related]
7. ubr5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer.
Xiang G; Wang S; Chen L; Song M; Song X; Wang H; Zhou P; Ma X; Yu J
Cell Death Dis; 2022 May; 13(5):451. PubMed ID: 35551175
[TBL] [Abstract] [Full Text] [Related]
8. Tumor targetable and pH-sensitive polymer nanoparticles for simultaneously improve the Type 2 Diabetes Mellitus and malignant breast cancer.
Tang S; Wen P; Li K; Deng J; Yang B
Bioengineered; 2022 Apr; 13(4):9754-9765. PubMed ID: 35411835
[TBL] [Abstract] [Full Text] [Related]
9. Considerations to increase rates of breast cancer screening across populations.
Patt D; Gordan L; Patel K; Okon T; Ferreyros N; Markward N; Sullivan M; Burnett B; Getachew B; Harris C
Am J Manag Care; 2022 Apr; 28(3 Spec. No.):SP136-SP138. PubMed ID: 35285592
[TBL] [Abstract] [Full Text] [Related]
10. Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human breast cancer.
Liao TT; Han JF; Zhang FY; Na R; Ye WL
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885691
[TBL] [Abstract] [Full Text] [Related]
11. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
[TBL] [Abstract] [Full Text] [Related]
12. Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0/G1 arrest and apoptosis.
Song Y; Li L; Chen J; Chen H; Cui B; Feng Y; Zhang P; Zhang Q; Xia Y; Luo M
Cell Cycle; 2020 Dec; 19(24):3521-3533. PubMed ID: 33315498
[TBL] [Abstract] [Full Text] [Related]
13. Activation of the Ir-N(pyridine) Bond in Half-Sandwich Tethered Iridium(III) Complexes.
Carrasco AC; Rodríguez-Fanjul V; Pizarro AM
Inorg Chem; 2020 Nov; 59(22):16454-16466. PubMed ID: 33103884
[TBL] [Abstract] [Full Text] [Related]
14. ubr5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.
Yang Y; Zhao J; Mao Y; Lin G; Li F; Jiang Z
Breast Cancer Res Treat; 2020 Dec; 184(3):699-710. PubMed ID: 32914356
[TBL] [Abstract] [Full Text] [Related]
15. The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines ± Trastuzumab: a Meta-analysis of clinical studies.
Elghazawy H; Venkatesulu BP; Verma V; Pushparaji B; Monlezun DJ; Marmagkiolis K; Iliescu CA
Crit Rev Oncol Hematol; 2020 Sep; 153():103006. PubMed ID: 32777728
[TBL] [Abstract] [Full Text] [Related]
16. Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.
Song M; Wang C; Wang H; Zhang T; Li J; Benezra R; Chouchane L; Sun YH; Cui XG; Ma X
Oncoimmunology; 2020; 9(1):1746148. PubMed ID: 32363114
[TBL] [Abstract] [Full Text] [Related]
17.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract] [Full Text] [Related]
18. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy.
Liu M; Wang B; Guo C; Hou X; Cheng Z; Chen D
Drug Deliv; 2019 Dec; 26(1):1002-1016. PubMed ID: 31571501
[TBL] [Abstract] [Full Text] [Related]
19. Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis.
Peng M; Yang D; Hou Y; Liu S; Zhao M; Qin Y; Chen R; Teng Y; Liu M
Cell Death Dis; 2019 Mar; 10(3):228. PubMed ID: 30850587
[TBL] [Abstract] [Full Text] [Related]
20. Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.
Khalid S; Hanif R; Jabeen I; Mansoor Q; Ismail M
PLoS One; 2018; 13(5):e0196312. PubMed ID: 29787591
[TBL] [Abstract] [Full Text] [Related]
[Next]
